Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigette B Y Ma

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Oral Oncology|January 17, 2021
Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinomaDavid Johnson, Brigette B Y Ma
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 13, 2013
Personalizing therapy for colorectal cancerAshley Wong, Brigette B Y Ma
Cancer Cell|May 19, 2023
Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancerBrigette B Y Ma, Quynh Thu Le
Cancer|November 27, 2004
Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinomaBrigette B Y Ma, Anthony T C Chan
Expert Review of Anticancer Therapy|March 1, 2006
Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinomaBrigette B Y Ma, Anthony T C Chan
Current Oncology Reports|March 22, 2012
Management of hepatocellular carcinoma: beyond sorafenibStephen L Chan, Tony Mok, Brigette B Y Ma
Hematology/Oncology Clinics of North America|January 7, 2003
Clinical trial designs for targeted agentsBrigette B Y Ma, Carolyn D Britten, Lillian L Siu
Current Opinion in Oncology|March 17, 2020
The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinomaEdwin Pun Hui, Brigette B Y Ma, Anthony T C Chan
Cancer Science|May 24, 2008
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directionsBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Expert Opinion on Investigational Drugs|April 28, 2017
Investigational drugs for nasopharyngeal carcinomaBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Oral Oncology|January 17, 2021
Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinomaDavid Johnson, Brigette B Y Ma
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 13, 2013
Personalizing therapy for colorectal cancerAshley Wong, Brigette B Y Ma
Cancer Cell|May 19, 2023
Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancerBrigette B Y Ma, Quynh Thu Le
Cancer|November 27, 2004
Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinomaBrigette B Y Ma, Anthony T C Chan
Expert Review of Anticancer Therapy|March 1, 2006
Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinomaBrigette B Y Ma, Anthony T C Chan
Current Oncology Reports|March 22, 2012
Management of hepatocellular carcinoma: beyond sorafenibStephen L Chan, Tony Mok, Brigette B Y Ma
Hematology/Oncology Clinics of North America|January 7, 2003
Clinical trial designs for targeted agentsBrigette B Y Ma, Carolyn D Britten, Lillian L Siu
Current Opinion in Oncology|March 17, 2020
The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinomaEdwin Pun Hui, Brigette B Y Ma, Anthony T C Chan
Cancer Science|May 24, 2008
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directionsBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Expert Opinion on Investigational Drugs|April 28, 2017
Investigational drugs for nasopharyngeal carcinomaBrigette B Y Ma, Edwin P Hui, Anthony T C Chan
Pageof 10